002630.KS
ORIENT BIO Inc.
KSC · Healthcare · Biotechnology · KR
KRW 1,229.00
−4.58%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.15x
- Price / sales
- 4.93x
- Price / cash flow
- 107.25x
Enterprise value
- Enterprise value
- KRW 115.6B
- EV / sales
- 3.91x
- EV / EBITDA
- -20.39x
- EV / EBIT
- -25.97x
- Market cap
- KRW 145.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025